Table I.
Patient characteristics.
| Characteristics | Total | Non-NAFLD | NAFLD | P-value |
|---|---|---|---|---|
| Patient, n | 293 | 125 | 168 | |
| Male/female, n | 140/153 | 62/63 | 78/90 | |
| Age, years | 67±13 | 63.4±12.9 | 69.4±12.8 | 0.0005 |
| ALP, IU/l | 241.7±91.4 | 225.1±81.9 | 253.0±63.9 | 0.0030 |
| AST, IU/l | 27.5±16.6 | 27.5±15.7 | 23.4±10.1 | <0.0001 |
| ALT, IU/l | 27.6±25.9 | 35.0±34.8 | 19.0±11.9 | <0.0001 |
| γ-GTP, IU/l | 48.2±66.6 | 51.1±28.7 | 39.5±56.0 | 0.0258 |
| HDL, mg/dl | 59.0±21.3 | 42.5±17.6 | 63.5±19.0 | 0.0002 |
| LDL, mg/dl | 115.7±28.5 | 114.2±35.5 | 112.7±23.9 | 0.0483 |
| TG, mg/dl | 128.2±75.2 | 160.8±129.9 | 104±56.8 | <0.0001 |
| BG, mg/dl | 122±47.5 | 133.2±40.8 | 112.6±42.7 | 0.0001 |
| HbA1c, % | 6.30±1.06 | 6.67±0.93 | 6.00±0.91 | <0.0001 |
Continuous variables are expressed as average ± standard deviation. NAFLD, nonalcoholic fatty liver disease; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; TG, triglyceride; BG, blood glucose; HbA1c, hemoglobin A1c.